Verdicts genuinely change. Free email alert the moment XLV's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
State Street(R) Health Care Select Sector SPDR(R) ETF ETF · SELECT SECTOR SPDR TRUST
65 holdings · as of 2026-06-30 (3.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT 23.05% of portfolio weight is in non-compliant holdings, over the 5% threshold.
65 holdings, 59 matched (100% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
0.87% of this portfolio’s income is non-permissible — weighted across holdings, computed over 86% of portfolio weight (53 of 65 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
76.6% compliant 0.0% questionable 23.1% non-compliant 0.3% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 16.51% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ Johnson & Johnson | COMPLIANT | 10.64% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| ABBV AbbVie Inc | COMPLIANT | 7.74% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 6.57% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| MRK Merck & Co Inc | COMPLIANT | 5.52% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| AMGN Amgen Inc | COMPLIANT | 3.40% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 3.24% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ABT Abbott Laboratories | COMPLIANT | 2.75% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| GILD Gilead Sciences Inc | COMPLIANT | 2.73% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.45% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| PFE Pfizer Inc | NON_COMPLIANT | 2.39% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| CVS CVS Health Corp | NON_COMPLIANT | 2.30% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 2.19% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| DHR Danaher Corp | COMPLIANT | 2.09% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 2.05% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| SYK Stryker Corp | COMPLIANT | 1.89% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| MDT Medtronic PLC | COMPLIANT | 1.75% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| MCK McKesson Corp | COMPLIANT | 1.58% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| ELV Elevance Health Inc | NON_COMPLIANT | 1.46% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| CI Cigna Group/The | NON_COMPLIANT | 1.27% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| BSX Boston Scientific Corp | COMPLIANT | 1.10% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| REGN Regeneron Pharmaceuticals Inc | COMPLIANT | 1.08% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| HCA HCA Healthcare Inc | NON_COMPLIANT | 1.05% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| CAH Cardinal Health Inc | COMPLIANT | 0.97% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| COR Cencora Inc | COMPLIANT | 0.96% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| EW Edwards Lifesciences Corp | COMPLIANT | 0.91% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| HUM Humana Inc | NON_COMPLIANT | 0.83% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.73% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| IDXX IDEXX Laboratories Inc | COMPLIANT | 0.72% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| A Agilent Technologies Inc | COMPLIANT | 0.65% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| WAT Waters Corp | COMPLIANT | 0.64% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.56% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| BIIB Biogen Inc | COMPLIANT | 0.56% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| ZTS Zoetis Inc | NON_COMPLIANT | 0.52% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| CNC Centene Corp | NON_COMPLIANT | 0.52% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| GEHC GE HealthCare Technologies Inc | NON_COMPLIANT | 0.51% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| RMD ResMed Inc | COMPLIANT | 0.49% | AAOIFI2.6% Usmani9.2% Dow Jones Islamic2.4% S&P Shariah2.6% MSCI Islamic9.2% MSCI Islamic M-Series2.6% FTSE Shariah7.4% |
| VEEV Veeva Systems Inc | NON_COMPLIANT | 0.46% | AAOIFI0.4% Usmani1.7% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.7% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| DXCM Dexcom Inc | COMPLIANT | 0.45% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| MTD Mettler-Toledo International Inc | COMPLIANT | 0.45% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| WST West Pharmaceutical Services Inc | COMPLIANT | 0.44% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| MRNA Moderna Inc | NON_COMPLIANT | 0.43% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| DGX Quest Diagnostics Inc | COMPLIANT | 0.41% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| LH Labcorp Holdings Inc | COMPLIANT | 0.40% | AAOIFI25.4% Usmani36.5% Dow Jones Islamic31.6% S&P Shariah33.5% MSCI Islamic36.2% MSCI Islamic M-Series33.5% FTSE Shariah31.6% |
| STE STERIS PLC | COMPLIANT | 0.36% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| INCY Incyte Corp | COMPLIANT | 0.33% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| VTRS Viatris Inc | NON_COMPLIANT | 0.32% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| ZBH Zimmer Biomet Holdings Inc | NON_COMPLIANT | 0.29% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| COO Cooper Cos Inc/The | COMPLIANT | 0.24% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| State Street Global Advisors | UNSCREENED | 0.23% | no in-house ratios for this holding |
| RVTY Revvity Inc | COMPLIANT | 0.22% | AAOIFI23.1% Usmani27.9% Dow Jones Islamic27.9% S&P Shariah27.2% MSCI Islamic27.9% MSCI Islamic M-Series27.2% FTSE Shariah26.7% |
| SOLV Solventum Corp | NON_COMPLIANT | 0.20% | AAOIFI32.5% Usmani37.1% Dow Jones Islamic39.6% S&P Shariah41.1% MSCI Islamic35.7% MSCI Islamic M-Series41.1% FTSE Shariah35.7% |
| ALGN Align Technology Inc | COMPLIANT | 0.20% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TECH Bio-Techne Corp | COMPLIANT | 0.19% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| BAX Baxter International Inc | NON_COMPLIANT | 0.19% | AAOIFI1.7% Usmani1.1% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic1.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| CRL Charles River Laboratories International Inc | COMPLIANT | 0.19% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| PODD Insulet Corp | COMPLIANT | 0.18% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| HSIC Henry Schein Inc | NON_COMPLIANT | 0.14% | AAOIFI36.7% Usmani32.3% Dow Jones Islamic41.6% S&P Shariah41.0% MSCI Islamic32.3% MSCI Islamic M-Series41.0% FTSE Shariah29.2% |
| UHS Universal Health Services Inc | NON_COMPLIANT | 0.14% | AAOIFI52.8% Usmani33.0% Dow Jones Islamic45.9% S&P Shariah48.2% MSCI Islamic33.0% MSCI Islamic M-Series48.2% FTSE Shariah30.4% |
| DVA DaVita Inc | NON_COMPLIANT | 0.12% | AAOIFI119.4% Usmani75.7% Dow Jones Islamic119.5% S&P Shariah122.0% MSCI Islamic75.7% MSCI Islamic M-Series122.0% FTSE Shariah60.9% |
| State Street Global Advisors | UNSCREENED | 0.01% | no in-house ratios for this holding |
| State Street Global Advisors | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Chicago Mercantile Exchange | UNSCREENED | 0.01% | no in-house ratios for this holding |
| State Street Global Advisors | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CONTRA HOLOGIC INCORPO | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 33 points of portfolio weight — 76.4% of it passes AAOIFI, 43.7% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 76.4% ratios fail on 14.8% 8.7% not rated under AAOIFI
ratios pass on 47.4% ratios fail on 43.8% 8.7% not rated under Usmani
ratios pass on 74.1% ratios fail on 17.1% 8.7% not rated under Dow Jones Islamic
ratios pass on 75.9% ratios fail on 15.3% 8.7% not rated under S&P Shariah
ratios pass on 43.7% ratios fail on 49.7% 6.5% not rated under MSCI Islamic
ratios pass on 74.9% ratios fail on 16.3% 8.7% not rated under MSCI Islamic M-Series
ratios pass on 48.6% ratios fail on 42.6% 8.7% not rated under FTSE Shariah
59 of 65 listed holdings carry our own per-methodology verdicts (100% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 53 (86% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 6.57% |
| PFE Pfizer Inc | 2.39% |
| CVS CVS Health Corp | 2.30% |
| BMY Bristol-Myers Squibb Co | 2.05% |
| ELV Elevance Health Inc | 1.46% |
| CI Cigna Group/The | 1.27% |
| HCA HCA Healthcare Inc | 1.05% |
| HUM Humana Inc | 0.83% |
| BDX Becton Dickinson & Co | 0.73% |
| IQV IQVIA Holdings Inc | 0.56% |
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
State Street(R) Health Care Select Sector SPDR(R) ETF (XLV) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
Computing the full ratio and business-activity breakdown for XLV — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Fisher | Fisher Asset Management | $24M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 66.20 | NEUTRAL |
| Stochastic %K (14) | 84.27 | SELL |
| CCI (20) | 226.68 | SELL |
| Williams %R (14) | -15.73 | SELL |
| MACD (12,26,9) | 0.90 | BUY |
| ROC (10) | 6.34 | BUY |
| Momentum (10) | 10.53 | BUY |
| EMA (10) | 172.40 | BUY |
| SMA (10) | 171.18 | BUY |
| EMA (20) | 170.81 | BUY |
| SMA (20) | 170.14 | BUY |
| EMA (30) | 169.97 | BUY |
| SMA (30) | 169.10 | BUY |
| EMA (50) | 168.30 | BUY |
| SMA (50) | 169.61 | BUY |
| EMA (100) | 164.03 | BUY |
| SMA (100) | 163.15 | BUY |
| EMA (200) | 158.51 | BUY |
| SMA (200) | 156.42 | BUY |
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 64 |
| ⏰ 4H | BULLISH | 47 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-13 · Asset managers net 915835 (+9220)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.